Macquarie Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $33.00
Surgery Partners (NASDAQ:SGRY – Get Free Report) had its price target reduced by analysts at Macquarie from $34.00 to $33.00 in a research report issued on Tuesday,Benzinga reports. The firm currently ...
Morgan Stanley Sticks to Its Buy Rating for Macquarie Group Limited (MCQEF)
In a report released today, Andrei Stadnik from Morgan Stanley maintained a Buy rating on Macquarie Group Limited (MCQEF – Research Report), ...